Telmisartan 40 mg/HCTZ 12.5 mg
Sponsors
Boehringer Ingelheim
Conditions
Hypertension
Phase 3
Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy
CompletedNCT00144222
Start: 2005-01-31End: 2005-08-31Updated: 2013-11-05
Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
CompletedNCT00326768
Start: 2006-05-31End: 2007-08-31Updated: 2017-12-28